Mar 062016

I was filling out a quick form on MS and it asked about treatments. I recognized all of them except one, Lemtrada. I thought wow I must have been living under a rock somewhere. Then a quick search and then I realized it is Campath with a new name. Apparently I was living under a rock since I missed the name change, etc., but now seems like a good time to revisit the drug.

I am glad I have the old information about the drug. It is now prescribed for relapsing-remitting types of patients who struggle on other drugs. What I find concerning is that, other than the drugs other horrible side effects, it kills oligodendrocytes which are key for myelin,and myelin repair. It makes me skeptocal of their claims, and peoples long-term outcomes. Bottom line it does not sound like an effective treatment that all but guarantees cancer, plus any number of other woes.

How do they even get this stuff approved as a treatment?

  One Response to “Lemtrada”

  1. Erik, I’m posting here because I was reading your blog last night and I can’t remember what I was searching for at the time. However I did look at your Igenex testing and your Lyme protocols. You are not terribly positive for Lyme.

    HOWEVER. Band 41 is extremely cross reactive for bartonella, which is not only a common co-infection of Lyme but may actually be even more prevalent. Hidden deep in the literature is a connection between bart and demyelinating diseases and diseases of the CNS. There are more strains than just the two most common ones and some are really virulent. Also hidden is a correlation between bart and MS.

    It is also resistant to treatment, and builds resistance very quickly to common antibiotics even in very high doses sometimes.

    Stephen Buhner has written a separate book on co-infections that contains an entire analysis of Bartonella and a full herbal protocol.

    If that doesn’t work, then you can work on HHV6 of course, with herbal antivirals, also ala Buhner.

    Just food for thought.

 Leave a Reply

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>